View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CMS | RIN: 0938-AV18 | Publication ID: Fall 2022 |
| Title: ●Hospital Outpatient Prospective Payment System: Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018-2022 (CMS-1793) | |
|
Abstract:
In response to the Supreme Court decision in American Hospital Association v. Becerra, 142 S. Ct. 1896 (2022), CMS will issue a notice of proposed rulemaking regarding potential remedies affecting cost years 2018-2022. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
| RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: Yes | Unfunded Mandates: No |
| CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
| Legal Authority: 42 U.S.C. 1395hh | |
|
Legal Deadline:
None |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Federalism: No | |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Elise Barringer Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C4-03-06, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-9222 Email: elise.barringer@cms.hhs.gov |
|
An official website of the United States government



